Hepion Pharmaceuticals replaces auditor Grassi with Rosenberg Rich Baker Berman
The company said Grassi & Co. was dismissed effective Sept. 22, 2026, and Rosenberg Rich Baker Berman was hired to audit 2026 consolidated financial statements.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.